Fusion Antibodies Share Discussion Threads

[timberwolf3] 16/4/2020 11:46

Think a lot of people have missed this one , FAB working with Queens University Belfast on covid 19 in the Coronavirus Antibody Development Alliance : This news has not been released as yet by FAB as far as i know.


New research alliance to seek new therapeutic and diagnostic approaches
Share
Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, have established a new research alliance with Queen’s to seek new therapeutic and diagnostic approaches to help in the global fight against the coronavirus pandemic.

The Northern Ireland Coronavirus Antibody Development Alliance (NICADA) aims to develop new therapeutic molecules that can be evaluated for their ability to neutralize SARS-CoV-2, the virus that causes COVID-19 disease.

Working with Professor Ultan Power in the Wellcome-Wolfson Institute of Experimental Medicine, Professor Chris Scott in The Patrick G Johnston Centre for Cancer Research and Dr Fuquan Lui in the School of Biological Sciences, at Queen’s University, Fusion Antibodies will prepare potential antibodies and engineer them specifically to neutralise the virus.

There is a shortage of key reagents for testing globally and although not a core service currently offered by the company, Fusion Antibodies will be using their expertise to develop key reagents that can be employed in the global challenge of COVID-19 testing.

Paul Kerr, CEO, Fusion Antibodies said:

“We are delighted to be able to assist in the global battle against Coronavirus. In the first instance we’ll work with Queen’s University Belfast to provide the key reagent which will be used for testing. Our expertise is focused on antibody development and we’ve already begun the process of engineering antibodies against COVID-19 using our advanced technology platforms.”

Professor Chris Scott, Director of the Patrick G Johnston Cancer Centre, Queen’s University Belfast, said

“By bringing together diverse researchers from virology, biological sciences and cancer research we are rapidly contributing to the development of new reagents that could not only neutralize the virus, but also aid diagnostic efforts; both of which are needed to inform decisions on lifting the current lockdown. We are delighted to initiate this alliance with Fusion Antibodies and to direct our research capabilities towards tackling this global pandemic”.

Ultan Power, Professor of Molecular Virology, Queen’s University Belfast said:

"The NICADA alliance provides an excellent opportunity to generate novel therapeutics and diagnostics to help the global fight against SARS-CoV-2.”
The NICADA alliance is actively harnessing the best scientific talent to tackle the global coronavirus pandemic.

For more information about Queen's work in response to the coronavirus, visit: hxxps://www.qub.ac.uk/coronavirus/

About Fusion Antibodies

Fusion Antibodies delivers new technology and innovation throughout early-stage antibody discovery. As a drug discovery and research partner, our scientists increase the pace to the clinic by guiding clients to develop the best antibodies possible. Through the early stages of drug discovery, we enable biotechnology and pharmaceutical organisations towards their end-goal - the provision of treatments that improve the lives of patients throughout the world.

Fusion Antibodies expertise is defined by our experience. Our tailored consultancy begins with the end in mind, helping clients solve complex problems. Our approach to projects considers long-term impacts on safety, efficacy and manufacturability at all stages. As an independent team, we maximise resources by offering the flexibility and agility that antibody discovery and development programmes require. This approach de-risks your programme and maximises success of your molecule to the next stage.

[fillipe] 29/1/2020 16:26

Good to see the upwards of today.

f

[tartshagger] 13/1/2020 16:53

Usually a good sign when a non-exec buys - this purchase matches Alan Mawson's similar purchase at the beginning of December and the mm has pushed the share price up 5.5% today, nice!

[sharesoc] 26/11/2019 21:40

The Fusion Antibody presentation from our recent London company seminar can be found in our members area here:

To access the presentation, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here:

Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the presentation (and presentations on 100s of other meetings). If you're already a member and have any difficulty accessing the report, please do not hesitate to contact us here:

[jonwig] 15/11/2019 08:45

Interview with FD. You might have to register, but then it's free:

[sharesoc] 31/10/2019 19:01

Fusion Antibodies present at our next London seminar on the 13th November which may be of interest to potential investors and current shareholders. More details and registration here:

[fillipe] 29/7/2019 15:04

Today - bingo!

f.

[si c] 17/7/2019 12:57

Has there actually been 1 trade in this stock so far this week?

[fillipe] 02/7/2019 09:21

A year on, FAB is being quite perky and still very much unknown.

f

[tartshagger] 01/5/2019 12:09

Did anybody go to yesterdays investor presentation?

[fillipe] 01/5/2019 10:31

FAB doing stonkingly well!

If they can do this way at a time when they still remains largely unknown, well what a great future for this share.

f

[babbler] 26/4/2019 13:10

Nice one. Think we are the main buyers lol

[bckttsim] 26/4/2019 13:02

69.95p is a buy ...... it's mine

[bckttsim] 26/4/2019 11:20

You must mean the bit about......Significant increase in orders and revenues in H2 FY 2019OrRAMP - will significantly increase revenues going forward FY 2019 and 2020.Quite good statements.

[babbler] 26/4/2019 11:07

shhh... Read last 3 rnss

[bckttsim] 26/4/2019 10:37

Only just saying on LSE that this must have been one of the top stocks this week, and on very few trades.Cannot believe so little attention to what's happening here.

[bckttsim] 26/4/2019 09:23

Well FAB is up again, I was looking at its history, listed last year at £18mil M/C.Took off to start with, went over £2 share. They gave a profit warning and it sunk.Now they are extremely upbeat on their going forward performance. Read the last RNS.It would not surprise me if it tested £2 before very much longer again.

[babbler] 25/4/2019 15:39

cheers. Seems good value but cab you get quote to sell?

[fillipe] 25/4/2019 15:34

Just info... there are three mm's on each side of the bid/ask and each show only 3k shares on each side.

So, a total only 9k of shares on show, but if such as "Quote and Deal" in 15 secs is not offering, then a Limit Order is almost certain to be filled.

It's 55p v 57p at the best bid/ask.

f

[bckttsim] 25/4/2019 13:10

You can only buy a few online

[babbler] 25/4/2019 12:16

yup and can't buy. May do nt. But hate doing that... tried since yesterday

[bckttsim] 25/4/2019 12:16

And there is this to consider, bearing in mind it was over £2 a share not long ago ....Significant increase in orders and revenues in H2 FY 2019